Bernd Erhart

Title: Bernd Erhart: Innovator in Pharmaceutical Chemistry

Introduction

Bernd Erhart is a notable inventor based in Kahla, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for synthesizing complex chemical compounds. With a total of 4 patents to his name, Erhart's work has had a considerable impact on the pharmaceutical industry.

Latest Patents

One of his latest patents is a method for preparing 4-[17β-methoxy-17α-methoxymethyl-3-oxoestra-4,9-dien-11β-yl]benzaldehyde (E)-oxime, also known as asoprisnil. This invention focuses on a reliable and reproducible preparation method that can be scaled for pilot and manufacturing purposes. Asoprisnil is characterized by excellent physical stability, making it particularly suitable for the production of solid pharmaceutical forms such as tablets and coated tablets. Another significant patent involves the production of 4-(17α-methyl-substituted 3-oxoestra-4,9-dien-11β-yl)benzaldehyde-(1E or 1Z)-oximes. This process yields target compounds with high efficiency and selectivity, showcasing Erhart's expertise in chemical synthesis.

Career Highlights

Throughout his career, Bernd Erhart has worked with prominent companies in the pharmaceutical sector, including Schering Aktiengesellschaft and Jenapharm GmbH. His experience in these organizations has allowed him to refine his skills and contribute to innovative projects that advance pharmaceutical research and development.

Collaborations

Erhart has collaborated with notable colleagues such as Sven Ring and Gerd Schubert. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical chemistry.

Conclusion

In summary, Bernd Erhart is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations and patents. His contributions continue to influence the development of effective pharmaceutical products.